328 related articles for article (PubMed ID: 29139296)
1. Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions.
Geis-Asteggiante L; Belew AT; Clements VK; Edwards NJ; Ostrand-Rosenberg S; El-Sayed NM; Fenselau C
J Proteome Res; 2018 Jan; 17(1):486-498. PubMed ID: 29139296
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
Burke M; Choksawangkarn W; Edwards N; Ostrand-Rosenberg S; Fenselau C
J Proteome Res; 2014 Feb; 13(2):836-43. PubMed ID: 24295599
[TBL] [Abstract][Full Text] [Related]
3. Molecular cargo in myeloid-derived suppressor cells and their exosomes.
Fenselau C; Ostrand-Rosenberg S
Cell Immunol; 2021 Jan; 359():104258. PubMed ID: 33338939
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
5. Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice.
Wang Y; Tian J; Tang X; Rui K; Tian X; Ma J; Ma B; Xu H; Lu L; Wang S
Oncotarget; 2016 Mar; 7(13):15356-68. PubMed ID: 26885611
[TBL] [Abstract][Full Text] [Related]
6. Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.
Zöller M
Front Immunol; 2018; 9():137. PubMed ID: 29456536
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata.
Zöller M; Zhao K; Kutlu N; Bauer N; Provaznik J; Hackert T; Schnölzer M
Front Immunol; 2018; 9():1279. PubMed ID: 29951053
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
[TBL] [Abstract][Full Text] [Related]
9. Isolation and immunosuppressive functions of myeloid-derived suppressor cell-derived exosomes.
Parvin M; Rashid MH; Arbab AS
Methods Cell Biol; 2024; 184():105-118. PubMed ID: 38555151
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.
Shokati E; Safari E
Int Immunopharmacol; 2023 Jul; 120():110267. PubMed ID: 37276829
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles released by myeloid-derived suppressor cells from pregnant women modulate adaptive immune responses.
Dietz S; Schwarz J; Rühle J; Schaller M; Fehrenbacher B; Marmé A; Schmid E; Peter A; Poets CF; Gille C; Köstlin-Gille N
Cell Immunol; 2021 Mar; 361():104276. PubMed ID: 33517124
[TBL] [Abstract][Full Text] [Related]
12. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
Sangaletti S; Talarico G; Chiodoni C; Cappetti B; Botti L; Portararo P; Gulino A; Consonni FM; Sica A; Randon G; Di Nicola M; Tripodo C; Colombo MP
Front Immunol; 2019; 10():1369. PubMed ID: 31281314
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer.
Metzger P; Kirchleitner SV; Kluge M; Koenig LM; Hörth C; Rambuscheck CA; Böhmer D; Ahlfeld J; Kobold S; Friedel CC; Endres S; Schnurr M; Duewell P
J Immunother Cancer; 2019 Nov; 7(1):288. PubMed ID: 31694706
[TBL] [Abstract][Full Text] [Related]
15. Plasticity and biological diversity of myeloid derived suppressor cells.
Ben-Meir K; Twaik N; Baniyash M
Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly.
Betsch A; Rutgeerts O; Fevery S; Sprangers B; Verhoef G; Dierickx D; Beckers M
Blood Rev; 2018 Nov; 32(6):490-498. PubMed ID: 29691090
[TBL] [Abstract][Full Text] [Related]
17. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
18. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
[TBL] [Abstract][Full Text] [Related]
19. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.
Chalmin F; Ladoire S; Mignot G; Vincent J; Bruchard M; Remy-Martin JP; Boireau W; Rouleau A; Simon B; Lanneau D; De Thonel A; Multhoff G; Hamman A; Martin F; Chauffert B; Solary E; Zitvogel L; Garrido C; Ryffel B; Borg C; Apetoh L; Rébé C; Ghiringhelli F
J Clin Invest; 2010 Feb; 120(2):457-71. PubMed ID: 20093776
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice.
Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M
Int Immunopharmacol; 2017 Jun; 47():173-181. PubMed ID: 28411578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
